View ValuationWestaim 将来の成長Future 基準チェック /06現在、 Westaimの成長と収益を予測するのに十分なアナリストの調査がありません。主要情報n/a収益成長率n/aEPS成長率Capital Markets 収益成長7.4%収益成長率n/a将来の株主資本利益率n/aアナリストカバレッジNone最終更新日n/a今後の成長に関する最新情報更新なしすべての更新を表示Recent updatesReported Earnings • May 20First quarter 2026 earnings released: US$1.00 loss per share (vs US$0.34 loss in 1Q 2025)First quarter 2026 results: US$1.00 loss per share (further deteriorated from US$0.34 loss in 1Q 2025). Net loss: US$33.3m (loss widened 349% from 1Q 2025). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 103 percentage points per year, which is a significant difference in performance.Board Change • May 20High number of new directorsThere are 7 new directors who have joined the board in the last 3 years. Executive Chairman of the Board Chinh Chu was the last director to join the board, commencing their role in 2025. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.お知らせ • Mar 17The Westaim Corporation, Annual General Meeting, May 19, 2026The Westaim Corporation, Annual General Meeting, May 19, 2026. Location: new york, new york United Statesお知らせ • Feb 11+ 1 more updateThe Westaim Corporation Announces Appointment of Matthew Skurbe as President and Chief Operating Officer, Effective April 1, 2026The Westaim Corporation announced that Matthew Skurbe will become President and Chief Operating Officer of Westaim, effective April 1, 2026. In this new role, Mr. Skurbe will leverage his over 25 years of broad financial services experience, which has included investment management, risk management, capital markets, operational, and financial responsibilities, to oversee strategic and operational initiatives across Westaim’s platform. Mr. Skurbe joined Westaim in April 2025 as Chief Financial Officer and Chief Risk Officer. Prior to Westaim, he served as a Senior Managing Director, Chief Operating Officer, and Chief Financial Officer of CC Capital. Prior to CC Capital, Mr. Skurbe was a Managing Director in Finance and the Treasurer for Blackstone. He was also the COO and portfolio manager for Blackstone Liquidity Solutions and a member of the firm's Valuation Committee and Enterprise Risk Committee. Before joining Blackstone in 2009, Mr. Skurbe was the CFO for Merrill Lynch Bank & Trust, a multi-billion-dollar bank housing several of Merrill Lynch's consumer lending and banking businesses. Earlier in his career, Mr. Skurbe spent seven years supporting Merrill Lynch'sTreasury function and held roles with Amerada Hess and Arthur Andersen LLP.お知らせ • Apr 07The Westaim Corporation, Annual General Meeting, Jun 12, 2025The Westaim Corporation, Annual General Meeting, Jun 12, 2025. Location: ontario, toronto Canadaお知らせ • Apr 04The Westaim Corporation announced that it has received CAD 341.525 million in fundingOn April 3, 2025, The Westaim Corporation closed the transaction. The company issued securities for aggregate gross proceeds to the company of CAD 250 million pursuant to an investment agreement the Investor, Westaim, and, solely for purposes of specific sections of the investment agreement, AIGH, Mr. Zwirn and Mr. Cutler, as amended on November 15, 2024: (a) 11,979,825 common shares of Westaim at an implied purchase price of CAD 28.50 per share in cash; and (b) warrants to purchase 5,214,705 additional Common Shares, comprised of (i) Warrants to purchase 1,303,676 Common Shares having an exercise price of CAD 24.12 per Common Share, which Warrants will vest in the event the volume-weighted average trading price of the Common Shares on the TSX Venture Exchange or other stock exchange on which the Common Shares are listed for trading equals or exceeds CAD 48.00 for any 30 consecutive trading day period prior to the five-year anniversary of the Closing Date; and (ii) Warrants to purchase 3,911,029 Common Shares having an exercise price of CAD 28.50 per Common Share. The Warrants are exercisable for a period of five years following the Closing Date and the number of Common Shares issuable pursuant to the Warrants and the exercise prices thereof are subject to certain adjustments. Prior to entering into the Investment Agreement, CC Capital and its affiliates did not beneficially own or control, directly or indirectly, any of the issued and outstanding Common Shares. As of the Closing Date, the Investor owns approximately 36% of the issued and outstanding Common Shares. If the Warrants were exercised in full and no other outstanding securities of Westaim were converted into Common Shares, as of the Closing Date the Investor would own approximately 44% of the issued and outstanding Common Shares.お知らせ • Apr 03The Westaim Corporation Announces Management ChangesCC Capital announced pursuant to an investor rights agreement among The Westaim Corporation (Westaim), Wembley Group Partners, LP (the Investor), an affiliate of CC Capital, and Arena Investors Group Holdings, LLC (AIGH) dated as of April 3, 2025 (the Investor Rights Agreement), Mr. Chinh Chu, Founder and Senior Managing Director of CC Capital has been appointed Executive Chair of the Westaim Board and Ian Delaney has transitioned to Vice Chair of the Westaim Board. In addition, pursuant to the Investor Rights Agreement, the size of the Westaim Board has been increased to 11 with four additional CC Capital nominees having been appointed as directors of Westaim, being Ms. Deanna Mulligan, former CEO and Chair of Guardian Life Insurance, Douglas Newton, Matthew Skurbe and Richard DiBlasi, as well as one director mutually selected by Westaim and CC Capital having been appointed, being Menes Chee. Dan Zwirn, CEO and Chief Investment Officer of Arena Investors, LP, will also be an observer on the Westaim Board. John Gildner and Lisa Mazzocco resigned from the Westaim Board. Further, Mr. Matthew Skurbe has been appointed as Chief Risk Officer of Westaim.お知らせ • Jan 08The Westaim Corporation Appoints Menes Chee as Independent Non-Executive DirectorThe Westaim Corporation announced that it will appoint Menes O. Chee to its Board of Directors as an independent, non-executive director upon the closing of the Company’s previously announced transaction with CC Capital, a private investment firm focused on investing in and operating high-quality businesses for the long term. Mr. Chee will assume the role of the Independent Director under the investor rights agreement to be entered into upon closing of the Transaction, alongside five directors to be appointed by an affiliate of CC Capital and five directors to be appointed by the Company. Mr. Chee was a Senior Managing Director of Blackstone Inc. from 2009 to 2024 and a founding partner and member of the investment committee of Blackstone’s Tactical Opportunities Group. Prior to joining Blackstone, Mr. Chee served as a Principal at TPG-Axon Capital and a private equity investment professional at Texas Pacific Group. He began his career at Donaldson Lufkin & Jenrette in the Leveraged Finance Group and worked at Credit Suisse First Boston in the Merchant Banking Group. Mr. Chee has served on numerous boards, including Ellington Residential Mortgage REIT, Acrisure Holdings Inc., DRB Capital LLC, Lia Holdings Ltd., New Point Ltd., Philadelphia Financial Group Inc. and Viva Capital. He graduated magna cum laude from the University of Pennsylvania with a B.S. in Economics from the Wharton School and a B.A. from the College of Arts and Sciences, where he was elected to Phi Beta Kappa.お知らせ • Jan 03The Westaim Corporation Announces Management ChangesThe Westaim Corporation has made certain changes to its management team. Robert Kittel has stepped down from his positions as Chief Operating Officer and Corporate Secretary of Westaim, and Ian Delaney has moved from Executive Chair of the Company’s board of directors to Chair of the Company’s board of directors, effective December 31, 2024. While stepping down from these officer roles, Mr. Kittel will serve as Chief Operating Officer of Westaim’s newly formed wholly-owned Canadian subsidiary, Westaim Canada Services Corporation. J. Cameron MacDonald will succeed Mr. Kittel as Corporate Secretary of the Company, while continuing in his roles as President and Chief Executive Officer of the Company.お知らせ • Dec 03+ 1 more updateThe Westaim Corporation Announces Chief Financial Officer ChangesThe Westaim Corporation announced that Matthew Skurbe will be appointed Chief Financial Officer (CFO). As CFO Mr. Skurbe will be responsible for leading all operational, financial and control processes for the Company. Upon assuming the roles of CFO of Westaim, Mr. Skurbe will transition into a senior advisor position at CC Capital as a Vice Chairman of the firm. Mr. Skurbe joins Westaim with proven experience as a CFO and expertise across financial and business functions. He currently serves as a Senior Managing Director and the Chief Operating Officer (“COO”) and CFO of CC Capital. Prior to joining CC Capital, Mr. Skurbe was a Managing Director in Finance and the Treasurer for Blackstone. He was also the COO for Blackstone Liquidity Solutions and a member of the firm's Valuation Committee and Enterprise Risk Committee. Before joining Blackstone in 2009, Mr. Skurbe was the CFO for Merrill Lynch Bank & Trust, a multi billion-dollar bank housing several of Merrill Lynch's consumer lending and banking businesses. Earlier in his career, Mr. Skurbe spent seven years supporting Merrill Lynch's Treasury function and held roles with Amerada Hess and Arthur Andersen LLP. Mr. Skurbe is a board member of Project Sunshine and the Children's Specialized Hospital Foundation. Mr. Skurbe will succeed Glenn MacNeil as CFO, who is retiring after nearly a decade in the role.Reported Earnings • Nov 14Third quarter 2024 earnings released: US$0.009 loss per share (vs US$0.17 profit in 3Q 2023)Third quarter 2024 results: US$0.009 loss per share (down from US$0.17 profit in 3Q 2023). Revenue: US$11.4m (down 54% from 3Q 2023). Net loss: US$1.17m (down 105% from profit in 3Q 2023). Revenue is forecast to decline by 126% p.a. on average during the next 2 years, while revenues in the Capital Markets industry in Germany are expected to remain flat. Over the last 3 years on average, earnings per share has increased by 56% per year but the company’s share price has only increased by 23% per year, which means it is significantly lagging earnings growth.Buy Or Sell Opportunity • Oct 30Now 20% undervaluedOver the last 90 days, the stock has risen 20% to €3.16. The fair value is estimated to be €3.96, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 74% over the last 3 years. Earnings per share has grown by 77%.Buy Or Sell Opportunity • Oct 12Now 25% undervaluedOver the last 90 days, the stock has risen 11% to €2.88. The fair value is estimated to be €3.82, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 74% over the last 3 years. Earnings per share has grown by 77%.お知らせ • Oct 11The Westaim Corporation announced that it expects to receive CAD 343.827501 million in funding from CC CapitalThe Westaim Corporation announced a private placement that it will issue 72,384,737 common shares at an issue price of CAD 4.75 per share and warrants that will represent an approximately 41% interest in the company for the aggregate gross proceeds of CAD 343,827,501 on October 9, 2024. The transaction will include participation from CC Capital. The parties expect to complete the transaction by the end of the first quarter of 2025, subject to receipt of certain regulatory approvals including, without limitation, approval of the TSXV, approval by Westaim shareholders and satisfaction of other customary closing conditions.Valuation Update With 7 Day Price Move • Oct 09Investor sentiment improves as stock rises 23%After last week's 23% share price gain to €3.22, the stock trades at a trailing P/E ratio of 6.9x. Average forward P/E is 10x in the Capital Markets industry in Germany. Total returns to shareholders of 71% over the past three years.お知らせ • Sep 11An undisclosed buyer acquired an unknown minority stake in Skyward Specialty Insurance Group, Inc. (NasdaqGS:SKWD) from The Westaim Corporation (TSXV:WED) for $79 million.An undisclosed buyer acquired an unknown minority stake in Skyward Specialty Insurance Group, Inc. (NasdaqGS:SKWD) from The Westaim Corporation (TSXV:WED) for $79 million on September 10, 2024. The Westaim Corporation sold the remaining 1,919,639 common shares it held. An undisclosed buyer completed the acquisition of an unknown minority stake in Skyward Specialty Insurance Group, Inc. (NasdaqGS:SKWD) from The Westaim Corporation (TSXV:WED) on September 10, 2024.Reported Earnings • Aug 15Second quarter 2024 earnings released: US$0.13 loss per share (vs US$0.22 profit in 2Q 2023)Second quarter 2024 results: US$0.13 loss per share (down from US$0.22 profit in 2Q 2023). Net loss: US$17.1m (down 154% from profit in 2Q 2023). Over the last 3 years on average, earnings per share has increased by 77% per year but the company’s share price has only increased by 18% per year, which means it is significantly lagging earnings growth.Reported Earnings • May 16First quarter 2024 earnings released: EPS: US$0.18 (vs US$0.67 in 1Q 2023)First quarter 2024 results: EPS: US$0.18 (down from US$0.67 in 1Q 2023). Revenue: US$28.8m (down 71% from 1Q 2023). Net income: US$23.3m (down 75% from 1Q 2023). Profit margin: 81% (down from 96% in 1Q 2023). The decrease in margin was primarily driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 97% per year but the company’s share price has only increased by 13% per year, which means it is significantly lagging earnings growth.Reported Earnings • Mar 28Full year 2023 earnings released: EPS: US$1.36 (vs US$0.13 in FY 2022)Full year 2023 results: EPS: US$1.36 (up from US$0.13 in FY 2022). Revenue: US$212.8m (up US$185.3m from FY 2022). Net income: US$184.0m (up US$166.0m from FY 2022). Profit margin: 87% (up from 66% in FY 2022). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 116% per year but the company’s share price has only increased by 11% per year, which means it is significantly lagging earnings growth.お知らせ • Mar 08The Westaim Corporation, Annual General Meeting, May 16, 2024The Westaim Corporation, Annual General Meeting, May 16, 2024.Reported Earnings • Nov 16Third quarter 2023 earnings released: EPS: US$0.17 (vs US$0.12 loss in 3Q 2022)Third quarter 2023 results: EPS: US$0.17 (up from US$0.12 loss in 3Q 2022). Net income: US$23.1m (up US$39.8m from 3Q 2022). Revenue is expected to decline by 115% p.a. on average during the next 2 years, while revenues in the Capital Markets industry in Germany are expected to grow by 1.6%. Over the last 3 years on average, earnings per share has increased by 124% per year but the company’s share price has only increased by 19% per year, which means it is significantly lagging earnings growth.お知らせ • Sep 22the Westaim Corporation Announces Appointment of Michael Siegel Independent DirectorThe Westaim Corporation announce the appointment of Michael Siegel to its board of directors as an independent non-executive director, effective September 21, 2023. Michael Siegel is the Founder and CEO of Legeis Capital, an advisory firm focused on the intersection of insurance and asset management. Prior to forming Legeis Capital, Michael was a Managing Director at RBC Capital Markets and served as the President & CEO of RBC Alternative Asset Management, LLC. He previously held investment management roles at hedge fund advisors CR Intrinsic Investors and DKR Capital. Michael began his career as a corporate and securities attorney at Covington & Burling LLP. He received a law degree from Harvard Law School and received his undergraduate degree in policy analysis and economics from Cornell University.Recent Insider Transactions • Sep 19President recently sold €235k worth of stockOn the 12th of September, John MacDonald sold around 96k shares on-market at roughly €2.45 per share. This transaction amounted to 2.7% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. This was John's only on-market trade for the last 12 months.Recent Insider Transactions • Sep 10Key Executive recently sold €115k worth of stockOn the 5th of September, Ian Delaney sold around 47k shares on-market at roughly €2.44 per share. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. Despite the recent sale, Ian has been a net buyer over the last 12 months, purchasing a net total of €436k worth of shares.Reported Earnings • Aug 16Second quarter 2023 earnings releasedSecond quarter 2023 results: Revenue: US$35.9m (up US$35.5m from 2Q 2022). Net income: US$31.4m (up US$32.9m from 2Q 2022). Profit margin: 87% (up from net loss in 2Q 2022). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 125% per year but the company’s share price has only increased by 22% per year, which means it is significantly lagging earnings growth.Board Change • Jun 01Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 4 highly experienced directors. Independent Director Kevin Parker was the last director to join the board, commencing their role in 2020. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Recent Insider Transactions • May 25Chief Financial Officer recently bought €54k worth of stockOn the 19th of May, Glenn MacNeil bought around 25k shares on-market at roughly €2.16 per share. This transaction amounted to 7.1% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Glenn has been a buyer over the last 12 months, purchasing a net total of €93k worth in shares.Reported Earnings • May 18First quarter 2023 earnings released: EPS: US$0.67 (vs US$0.025 in 1Q 2022)First quarter 2023 results: EPS: US$0.67 (up from US$0.025 in 1Q 2022). Revenue: US$98.8m (up US$91.8m from 1Q 2022). Net income: US$94.5m (up US$91.0m from 1Q 2022). Profit margin: 96% (up from 50% in 1Q 2022). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 115% per year but the company’s share price has only increased by 25% per year, which means it is significantly lagging earnings growth.Reported Earnings • Mar 31Full year 2022 earnings released: EPS: US$0.13 (vs US$0.20 in FY 2021)Full year 2022 results: EPS: US$0.13 (down from US$0.20 in FY 2021). Revenue: US$27.4m (down 19% from FY 2021). Net income: US$18.0m (down 36% from FY 2021). Profit margin: 66% (down from 84% in FY 2021). The decrease in margin was primarily driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 72% per year but the company’s share price has only increased by 24% per year, which means it is significantly lagging earnings growth.Recent Insider Transactions • Jan 27Insider recently bought €247k worth of stockOn the 24th of January, Parag Shah bought around 125k shares on-market at roughly €1.98 per share. This transaction amounted to 5.0% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought €845k more in shares than they have sold in the last 12 months.Reported Earnings • Nov 16Third quarter 2022 earnings released: US$0.12 loss per share (vs US$0.011 profit in 3Q 2021)Third quarter 2022 results: US$0.12 loss per share (down from US$0.011 profit in 3Q 2021). Net loss: US$16.8m (down US$18.4m from profit in 3Q 2021). Revenue is forecast to grow 240% p.a. on average during the next 2 years, compared to a 4.4% growth forecast for the Capital Markets industry in Germany. Over the last 3 years on average, earnings per share has increased by 31% per year but the company’s share price has fallen by 1% per year, which means it is significantly lagging earnings.Reported Earnings • Nov 12Third quarter 2022 earnings released: US$0.12 loss per share (vs US$0.011 profit in 3Q 2021)Third quarter 2022 results: US$0.12 loss per share (down from US$0.011 profit in 3Q 2021). Net loss: US$16.8m (down US$18.4m from profit in 3Q 2021). Revenue is forecast to grow 152% p.a. on average during the next 2 years, compared to a 4.4% growth forecast for the Capital Markets industry in Germany. Over the last 3 years on average, earnings per share has increased by 31% per year but the company’s share price has fallen by 1% per year, which means it is significantly lagging earnings.Reported Earnings • Aug 13Second quarter 2022 earnings released: US$0.011 loss per share (vs US$0.076 profit in 2Q 2021)Second quarter 2022 results: US$0.011 loss per share (down from US$0.076 profit in 2Q 2021). Revenue: US$388.0k (down 96% from 2Q 2021). Net loss: US$1.58m (down 115% from profit in 2Q 2021). Over the next year, revenue is forecast to grow 169% compared to a 2.6% decline forecast for the industry in Germany. Over the last 3 years on average, earnings per share has increased by 14% per year but the company’s share price has only increased by 4% per year, which means it is significantly lagging earnings growth.Recent Insider Transactions • Jun 17Insider recently bought €369k worth of stockOn the 14th of June, Parag Shah bought around 200k shares on-market at roughly €1.84 per share. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought €5.7m more in shares than they have sold in the last 12 months.Recent Insider Transactions • Jun 01Lead Independent Director recently bought €191k worth of stockOn the 30th of May, Stephen Cole bought around 100k shares on-market at roughly €1.91 per share. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought €5.4m more in shares than they have sold in the last 12 months.Reported Earnings • May 18First quarter 2022 earnings released: EPS: US$0.025 (vs US$0.064 in 1Q 2021)First quarter 2022 results: EPS: US$0.025 (down from US$0.064 in 1Q 2021). Revenue: US$7.01m (down 45% from 1Q 2021). Net income: US$3.52m (down 61% from 1Q 2021). Profit margin: 50% (down from 72% in 1Q 2021). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 6% per year but the company’s share price has remained flat, which means it is well ahead of earnings.Reported Earnings • Apr 15Full year 2021 earnings releasedFull year 2021 results: Revenue: US$33.7m (down 230% from FY 2020). Net income: US$28.2m (up US$62.6m from FY 2020). Profit margin: 84% (down from 132% in FY 2020). The decrease in margin was driven by lower revenue. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 63 percentage points per year, which is a significant difference in performance.Recent Insider Transactions • Jan 28Insider recently bought €84k worth of stockOn the 24th of January, Parag Shah bought around 50k shares on-market at roughly €1.69 per share. In the last 3 months, there was an even bigger purchase from another insider worth €1.2m. Insiders have collectively bought €6.2m more in shares than they have sold in the last 12 months.Recent Insider Transactions • Dec 08Insider recently bought €440k worth of stockOn the 3rd of December, James Hays bought around 250k shares on-market at roughly €1.76 per share. In the last 3 months, they made an even bigger purchase worth €1.2m. Insiders have collectively bought €6.1m more in shares than they have sold in the last 12 months.Recent Insider Transactions • Nov 25Insider recently bought €108k worth of stockOn the 22nd of November, James Hays bought around 60k shares on-market at roughly €1.81 per share. In the last 3 months, they made an even bigger purchase worth €2.0m. Insiders have collectively bought €4.6m more in shares than they have sold in the last 12 months.Reported Earnings • Nov 19Third quarter 2021 earnings releasedThe company reported a decent third quarter result with improved earnings and profit margins, although revenues were weaker. Third quarter 2021 results: Revenue: US$3.80m (down 6.1% from 3Q 2020). Net income: US$1.59m (up 143% from 3Q 2020). Profit margin: 42% (up from 16% in 3Q 2020). The increase in margin was driven by lower expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 85 percentage points per year, which is a significant difference in performance.Recent Insider Transactions • Sep 12Chief Financial Officer recently bought €58k worth of stockOn the 9th of September, Glenn MacNeil bought around 32k shares on-market at roughly €1.81 per share. In the last 3 months, there was an even bigger purchase from another insider worth €2.0m. Glenn has been a buyer over the last 12 months, purchasing a net total of €115k worth in shares.Recent Insider Transactions • Aug 29Insider recently bought €2.0m worth of stockOn the 26th of August, James Hays bought around 1m shares on-market at roughly €1.63 per share. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought €8.0m more in shares than they have sold in the last 12 months.Reported Earnings • Aug 20Second quarter 2021 earnings releasedSecond quarter 2021 results: Revenue: US$10.5m (up 182% from 2Q 2020). Net income: US$10.9m (up US$11.0m from 2Q 2020). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 88 percentage points per year, which is a significant difference in performance.Recent Insider Transactions • Jul 28Insider recently bought €994k worth of stockOn the 19th of July, James Hays bought around 750k shares on-market at roughly €1.33 per share. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought €6.0m more in shares than they have sold in the last 12 months.Reported Earnings • May 24First quarter 2021 earnings releasedThe company reported a soft first quarter result with weaker revenues and profit margins, although earnings were improved. First quarter 2021 results: Revenue: US$12.7m (down 153% from 1Q 2020). Net income: US$9.09m (up US$29.5m from 1Q 2020). Profit margin: 72% (down from 86% in 1Q 2020). The decrease in margin was driven by lower expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 89 percentage points per year, which is a significant difference in performance.Recent Insider Transactions • Apr 24Insider recently bought €258k worth of stockOn the 16th of April, James Hays bought around 137k shares on-market at roughly €1.88 per share. In the last 3 months, there was an even bigger purchase from another insider worth €509k. Insiders have collectively bought €11m more in shares than they have sold in the last 12 months.Recent Insider Transactions • Apr 01Executive Chairman of the Board recently bought €295k worth of stockOn the 29th of March, Ian Delaney bought around 165k shares on-market at roughly €1.79 per share. This was the largest purchase by an insider in the last 3 months. This was Ian's only on-market trade for the last 12 months.Reported Earnings • Mar 27Full year 2020 earnings releasedFull year 2020 results: Net loss: US$34.4m (down US$42.9m from profit in FY 2019).Is New 90 Day High Low • Mar 05New 90-day high: €1.80The company is up 22% from its price of €1.48 on 04 December 2020. The German market is up 8.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Capital Markets industry, which is up 10.0% over the same period.Is New 90 Day High Low • Feb 03New 90-day high: €1.68The company is up 12% from its price of €1.50 on 05 November 2020. The German market is up 16% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Capital Markets industry, which is up 14% over the same period.Is New 90 Day High Low • Jan 14New 90-day high: €1.62The company is up 7.0% from its price of €1.52 on 16 October 2020. The German market is up 10.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Capital Markets industry, which is up 12% over the same period.Is New 90 Day High Low • Dec 17New 90-day high: €1.54The company is up 10.0% from its price of €1.40 on 18 September 2020. The German market is up 2.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Capital Markets industry, which is up 4.0% over the same period.Recent Insider Transactions • Dec 03Insider recently bought €374k worth of stockOn the 30th of November, James Hays bought around 250k shares on-market at roughly €1.50 per share. In the last 3 months, they made an even bigger purchase worth €1.4m. Insiders have collectively bought €11m more in shares than they have sold in the last 12 months.Reported Earnings • Nov 14Third quarter 2020 earnings released: EPS US$0.005Third quarter 2020 results: Net income: US$655.0k (down 83% from 3Q 2019).Is New 90 Day High Low • Nov 10New 90-day high: €1.53The company is up 17% from its price of €1.31 on 12 August 2020. The German market is flat over the last 90 days, indicating the company outperformed over that time. It also outperformed the Capital Markets industry, which is down 3.0% over the same period.Is New 90 Day High Low • Oct 05New 90-day high: €1.46The company is up 12% from its price of €1.30 on 07 July 2020. The German market is flat over the last 90 days, indicating the company outperformed over that time. It also outperformed the Capital Markets industry, which is down 12% over the same period.Recent Insider Transactions • Sep 30Insider recently bought €203k worth of stockOn the 25th of September, James Hays bought around 143k shares on-market at roughly €1.42 per share. In the last 3 months, there was an even bigger purchase from another insider worth €616k. Insiders have collectively bought €7.7m more in shares than they have sold in the last 12 months. このセクションでは通常、投資家が会社の利益創出能力を理解する一助となるよう、プロのアナリストのコンセンサス予想に基づく収益と利益の成長予測を提示する。しかし、Westaim は十分な過去のデータを提供しておらず、アナリストの予測もないため、過去のデータを外挿したり、アナリストの予測を使用しても、その将来の収益を確実に算出することはできません。 シンプリー・ウォール・ストリートがカバーする企業の97%は過去の財務データを持っているため、これはかなり稀な状況です。 業績と収益の成長予測DB:7N4 - アナリストの将来予測と過去の財務データ ( )USD Millions日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数3/31/202687-643041N/A12/31/202568-38-13-5N/A9/30/202550-41-58-54N/A6/30/202543-29-71-70N/A3/31/20255-47-39-39N/A12/31/202439-16-47-47N/A9/30/20249140-32-32N/A6/30/202410464-16-16N/A3/31/2024143113-14-14N/A12/31/2023213184-3-3N/A9/30/2023195182-3-3N/A6/30/2023155142-4-4N/A3/31/2023119109-6-6N/A12/31/20222718-2-2N/A9/30/2022-1-8-3-3N/A6/30/20221810-3-3N/A3/31/20222823-2-2N/A12/31/20213428-5-5N/A9/30/2021177-3-3N/A6/30/2021176-3-3N/A3/31/202110-5-2-2N/A12/31/2020-26-341919N/A9/30/2020-26-332121N/A6/30/2020-25-302222N/A3/31/2020-18-222121N/A12/31/2019199N/A1N/A9/30/20193328N/A-3N/A6/30/20193529N/A-4N/A3/31/20192921N/A-3N/A12/31/20182117N/A-4N/A9/30/20182817N/A-2N/A6/30/20182719N/A-2N/A3/31/20182510N/A-1N/A12/31/2017246N/A0N/A9/30/201712-2N/A-1N/A6/30/20175-12N/A-2N/A3/31/2017-1-8N/A-4N/A12/31/2016-1-8N/A-4N/A9/30/2016-3-13N/A-5N/A6/30/2016-3-2N/A-4N/A3/31/20160-1N/A-3N/A12/31/2015-28N/A-2N/A9/30/2015920N/A-2N/A6/30/20152128N/A1N/Aもっと見るアナリストによる今後の成長予測収入対貯蓄率: 7N4の予測収益成長が 貯蓄率 ( 1.9% ) を上回っているかどうかを判断するにはデータが不十分です。収益対市場: 7N4の収益がGerman市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です高成長収益: 7N4の収益が今後 3 年間で 大幅に 増加すると予想されるかどうかを判断するにはデータが不十分です。収益対市場: 7N4の収益がGerman市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。高い収益成長: 7N4の収益が年間20%よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。一株当たり利益成長率予想将来の株主資本利益率将来のROE: 7N4の 自己資本利益率 が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です成長企業の発掘7D1Y7D1Y7D1YDiversified-financials 業界の高成長企業。View Past Performance企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/06/29 17:08終値2026/06/29 00:00収益2026/03/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社の Github ページ でご覧いただけます。また、レポートの使い方に関する ガイド や YouTube の チュートリアル もご用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋The Westaim Corporation 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。6 アナリスト機関Jeffrey FenwickATB CormarkVahan AjamianBeacon Securities LimitedPaul HoldenCIBC Capital Markets3 その他のアナリストを表示
Reported Earnings • May 20First quarter 2026 earnings released: US$1.00 loss per share (vs US$0.34 loss in 1Q 2025)First quarter 2026 results: US$1.00 loss per share (further deteriorated from US$0.34 loss in 1Q 2025). Net loss: US$33.3m (loss widened 349% from 1Q 2025). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 103 percentage points per year, which is a significant difference in performance.
Board Change • May 20High number of new directorsThere are 7 new directors who have joined the board in the last 3 years. Executive Chairman of the Board Chinh Chu was the last director to join the board, commencing their role in 2025. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.
お知らせ • Mar 17The Westaim Corporation, Annual General Meeting, May 19, 2026The Westaim Corporation, Annual General Meeting, May 19, 2026. Location: new york, new york United States
お知らせ • Feb 11+ 1 more updateThe Westaim Corporation Announces Appointment of Matthew Skurbe as President and Chief Operating Officer, Effective April 1, 2026The Westaim Corporation announced that Matthew Skurbe will become President and Chief Operating Officer of Westaim, effective April 1, 2026. In this new role, Mr. Skurbe will leverage his over 25 years of broad financial services experience, which has included investment management, risk management, capital markets, operational, and financial responsibilities, to oversee strategic and operational initiatives across Westaim’s platform. Mr. Skurbe joined Westaim in April 2025 as Chief Financial Officer and Chief Risk Officer. Prior to Westaim, he served as a Senior Managing Director, Chief Operating Officer, and Chief Financial Officer of CC Capital. Prior to CC Capital, Mr. Skurbe was a Managing Director in Finance and the Treasurer for Blackstone. He was also the COO and portfolio manager for Blackstone Liquidity Solutions and a member of the firm's Valuation Committee and Enterprise Risk Committee. Before joining Blackstone in 2009, Mr. Skurbe was the CFO for Merrill Lynch Bank & Trust, a multi-billion-dollar bank housing several of Merrill Lynch's consumer lending and banking businesses. Earlier in his career, Mr. Skurbe spent seven years supporting Merrill Lynch'sTreasury function and held roles with Amerada Hess and Arthur Andersen LLP.
お知らせ • Apr 07The Westaim Corporation, Annual General Meeting, Jun 12, 2025The Westaim Corporation, Annual General Meeting, Jun 12, 2025. Location: ontario, toronto Canada
お知らせ • Apr 04The Westaim Corporation announced that it has received CAD 341.525 million in fundingOn April 3, 2025, The Westaim Corporation closed the transaction. The company issued securities for aggregate gross proceeds to the company of CAD 250 million pursuant to an investment agreement the Investor, Westaim, and, solely for purposes of specific sections of the investment agreement, AIGH, Mr. Zwirn and Mr. Cutler, as amended on November 15, 2024: (a) 11,979,825 common shares of Westaim at an implied purchase price of CAD 28.50 per share in cash; and (b) warrants to purchase 5,214,705 additional Common Shares, comprised of (i) Warrants to purchase 1,303,676 Common Shares having an exercise price of CAD 24.12 per Common Share, which Warrants will vest in the event the volume-weighted average trading price of the Common Shares on the TSX Venture Exchange or other stock exchange on which the Common Shares are listed for trading equals or exceeds CAD 48.00 for any 30 consecutive trading day period prior to the five-year anniversary of the Closing Date; and (ii) Warrants to purchase 3,911,029 Common Shares having an exercise price of CAD 28.50 per Common Share. The Warrants are exercisable for a period of five years following the Closing Date and the number of Common Shares issuable pursuant to the Warrants and the exercise prices thereof are subject to certain adjustments. Prior to entering into the Investment Agreement, CC Capital and its affiliates did not beneficially own or control, directly or indirectly, any of the issued and outstanding Common Shares. As of the Closing Date, the Investor owns approximately 36% of the issued and outstanding Common Shares. If the Warrants were exercised in full and no other outstanding securities of Westaim were converted into Common Shares, as of the Closing Date the Investor would own approximately 44% of the issued and outstanding Common Shares.
お知らせ • Apr 03The Westaim Corporation Announces Management ChangesCC Capital announced pursuant to an investor rights agreement among The Westaim Corporation (Westaim), Wembley Group Partners, LP (the Investor), an affiliate of CC Capital, and Arena Investors Group Holdings, LLC (AIGH) dated as of April 3, 2025 (the Investor Rights Agreement), Mr. Chinh Chu, Founder and Senior Managing Director of CC Capital has been appointed Executive Chair of the Westaim Board and Ian Delaney has transitioned to Vice Chair of the Westaim Board. In addition, pursuant to the Investor Rights Agreement, the size of the Westaim Board has been increased to 11 with four additional CC Capital nominees having been appointed as directors of Westaim, being Ms. Deanna Mulligan, former CEO and Chair of Guardian Life Insurance, Douglas Newton, Matthew Skurbe and Richard DiBlasi, as well as one director mutually selected by Westaim and CC Capital having been appointed, being Menes Chee. Dan Zwirn, CEO and Chief Investment Officer of Arena Investors, LP, will also be an observer on the Westaim Board. John Gildner and Lisa Mazzocco resigned from the Westaim Board. Further, Mr. Matthew Skurbe has been appointed as Chief Risk Officer of Westaim.
お知らせ • Jan 08The Westaim Corporation Appoints Menes Chee as Independent Non-Executive DirectorThe Westaim Corporation announced that it will appoint Menes O. Chee to its Board of Directors as an independent, non-executive director upon the closing of the Company’s previously announced transaction with CC Capital, a private investment firm focused on investing in and operating high-quality businesses for the long term. Mr. Chee will assume the role of the Independent Director under the investor rights agreement to be entered into upon closing of the Transaction, alongside five directors to be appointed by an affiliate of CC Capital and five directors to be appointed by the Company. Mr. Chee was a Senior Managing Director of Blackstone Inc. from 2009 to 2024 and a founding partner and member of the investment committee of Blackstone’s Tactical Opportunities Group. Prior to joining Blackstone, Mr. Chee served as a Principal at TPG-Axon Capital and a private equity investment professional at Texas Pacific Group. He began his career at Donaldson Lufkin & Jenrette in the Leveraged Finance Group and worked at Credit Suisse First Boston in the Merchant Banking Group. Mr. Chee has served on numerous boards, including Ellington Residential Mortgage REIT, Acrisure Holdings Inc., DRB Capital LLC, Lia Holdings Ltd., New Point Ltd., Philadelphia Financial Group Inc. and Viva Capital. He graduated magna cum laude from the University of Pennsylvania with a B.S. in Economics from the Wharton School and a B.A. from the College of Arts and Sciences, where he was elected to Phi Beta Kappa.
お知らせ • Jan 03The Westaim Corporation Announces Management ChangesThe Westaim Corporation has made certain changes to its management team. Robert Kittel has stepped down from his positions as Chief Operating Officer and Corporate Secretary of Westaim, and Ian Delaney has moved from Executive Chair of the Company’s board of directors to Chair of the Company’s board of directors, effective December 31, 2024. While stepping down from these officer roles, Mr. Kittel will serve as Chief Operating Officer of Westaim’s newly formed wholly-owned Canadian subsidiary, Westaim Canada Services Corporation. J. Cameron MacDonald will succeed Mr. Kittel as Corporate Secretary of the Company, while continuing in his roles as President and Chief Executive Officer of the Company.
お知らせ • Dec 03+ 1 more updateThe Westaim Corporation Announces Chief Financial Officer ChangesThe Westaim Corporation announced that Matthew Skurbe will be appointed Chief Financial Officer (CFO). As CFO Mr. Skurbe will be responsible for leading all operational, financial and control processes for the Company. Upon assuming the roles of CFO of Westaim, Mr. Skurbe will transition into a senior advisor position at CC Capital as a Vice Chairman of the firm. Mr. Skurbe joins Westaim with proven experience as a CFO and expertise across financial and business functions. He currently serves as a Senior Managing Director and the Chief Operating Officer (“COO”) and CFO of CC Capital. Prior to joining CC Capital, Mr. Skurbe was a Managing Director in Finance and the Treasurer for Blackstone. He was also the COO for Blackstone Liquidity Solutions and a member of the firm's Valuation Committee and Enterprise Risk Committee. Before joining Blackstone in 2009, Mr. Skurbe was the CFO for Merrill Lynch Bank & Trust, a multi billion-dollar bank housing several of Merrill Lynch's consumer lending and banking businesses. Earlier in his career, Mr. Skurbe spent seven years supporting Merrill Lynch's Treasury function and held roles with Amerada Hess and Arthur Andersen LLP. Mr. Skurbe is a board member of Project Sunshine and the Children's Specialized Hospital Foundation. Mr. Skurbe will succeed Glenn MacNeil as CFO, who is retiring after nearly a decade in the role.
Reported Earnings • Nov 14Third quarter 2024 earnings released: US$0.009 loss per share (vs US$0.17 profit in 3Q 2023)Third quarter 2024 results: US$0.009 loss per share (down from US$0.17 profit in 3Q 2023). Revenue: US$11.4m (down 54% from 3Q 2023). Net loss: US$1.17m (down 105% from profit in 3Q 2023). Revenue is forecast to decline by 126% p.a. on average during the next 2 years, while revenues in the Capital Markets industry in Germany are expected to remain flat. Over the last 3 years on average, earnings per share has increased by 56% per year but the company’s share price has only increased by 23% per year, which means it is significantly lagging earnings growth.
Buy Or Sell Opportunity • Oct 30Now 20% undervaluedOver the last 90 days, the stock has risen 20% to €3.16. The fair value is estimated to be €3.96, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 74% over the last 3 years. Earnings per share has grown by 77%.
Buy Or Sell Opportunity • Oct 12Now 25% undervaluedOver the last 90 days, the stock has risen 11% to €2.88. The fair value is estimated to be €3.82, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 74% over the last 3 years. Earnings per share has grown by 77%.
お知らせ • Oct 11The Westaim Corporation announced that it expects to receive CAD 343.827501 million in funding from CC CapitalThe Westaim Corporation announced a private placement that it will issue 72,384,737 common shares at an issue price of CAD 4.75 per share and warrants that will represent an approximately 41% interest in the company for the aggregate gross proceeds of CAD 343,827,501 on October 9, 2024. The transaction will include participation from CC Capital. The parties expect to complete the transaction by the end of the first quarter of 2025, subject to receipt of certain regulatory approvals including, without limitation, approval of the TSXV, approval by Westaim shareholders and satisfaction of other customary closing conditions.
Valuation Update With 7 Day Price Move • Oct 09Investor sentiment improves as stock rises 23%After last week's 23% share price gain to €3.22, the stock trades at a trailing P/E ratio of 6.9x. Average forward P/E is 10x in the Capital Markets industry in Germany. Total returns to shareholders of 71% over the past three years.
お知らせ • Sep 11An undisclosed buyer acquired an unknown minority stake in Skyward Specialty Insurance Group, Inc. (NasdaqGS:SKWD) from The Westaim Corporation (TSXV:WED) for $79 million.An undisclosed buyer acquired an unknown minority stake in Skyward Specialty Insurance Group, Inc. (NasdaqGS:SKWD) from The Westaim Corporation (TSXV:WED) for $79 million on September 10, 2024. The Westaim Corporation sold the remaining 1,919,639 common shares it held. An undisclosed buyer completed the acquisition of an unknown minority stake in Skyward Specialty Insurance Group, Inc. (NasdaqGS:SKWD) from The Westaim Corporation (TSXV:WED) on September 10, 2024.
Reported Earnings • Aug 15Second quarter 2024 earnings released: US$0.13 loss per share (vs US$0.22 profit in 2Q 2023)Second quarter 2024 results: US$0.13 loss per share (down from US$0.22 profit in 2Q 2023). Net loss: US$17.1m (down 154% from profit in 2Q 2023). Over the last 3 years on average, earnings per share has increased by 77% per year but the company’s share price has only increased by 18% per year, which means it is significantly lagging earnings growth.
Reported Earnings • May 16First quarter 2024 earnings released: EPS: US$0.18 (vs US$0.67 in 1Q 2023)First quarter 2024 results: EPS: US$0.18 (down from US$0.67 in 1Q 2023). Revenue: US$28.8m (down 71% from 1Q 2023). Net income: US$23.3m (down 75% from 1Q 2023). Profit margin: 81% (down from 96% in 1Q 2023). The decrease in margin was primarily driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 97% per year but the company’s share price has only increased by 13% per year, which means it is significantly lagging earnings growth.
Reported Earnings • Mar 28Full year 2023 earnings released: EPS: US$1.36 (vs US$0.13 in FY 2022)Full year 2023 results: EPS: US$1.36 (up from US$0.13 in FY 2022). Revenue: US$212.8m (up US$185.3m from FY 2022). Net income: US$184.0m (up US$166.0m from FY 2022). Profit margin: 87% (up from 66% in FY 2022). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 116% per year but the company’s share price has only increased by 11% per year, which means it is significantly lagging earnings growth.
お知らせ • Mar 08The Westaim Corporation, Annual General Meeting, May 16, 2024The Westaim Corporation, Annual General Meeting, May 16, 2024.
Reported Earnings • Nov 16Third quarter 2023 earnings released: EPS: US$0.17 (vs US$0.12 loss in 3Q 2022)Third quarter 2023 results: EPS: US$0.17 (up from US$0.12 loss in 3Q 2022). Net income: US$23.1m (up US$39.8m from 3Q 2022). Revenue is expected to decline by 115% p.a. on average during the next 2 years, while revenues in the Capital Markets industry in Germany are expected to grow by 1.6%. Over the last 3 years on average, earnings per share has increased by 124% per year but the company’s share price has only increased by 19% per year, which means it is significantly lagging earnings growth.
お知らせ • Sep 22the Westaim Corporation Announces Appointment of Michael Siegel Independent DirectorThe Westaim Corporation announce the appointment of Michael Siegel to its board of directors as an independent non-executive director, effective September 21, 2023. Michael Siegel is the Founder and CEO of Legeis Capital, an advisory firm focused on the intersection of insurance and asset management. Prior to forming Legeis Capital, Michael was a Managing Director at RBC Capital Markets and served as the President & CEO of RBC Alternative Asset Management, LLC. He previously held investment management roles at hedge fund advisors CR Intrinsic Investors and DKR Capital. Michael began his career as a corporate and securities attorney at Covington & Burling LLP. He received a law degree from Harvard Law School and received his undergraduate degree in policy analysis and economics from Cornell University.
Recent Insider Transactions • Sep 19President recently sold €235k worth of stockOn the 12th of September, John MacDonald sold around 96k shares on-market at roughly €2.45 per share. This transaction amounted to 2.7% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. This was John's only on-market trade for the last 12 months.
Recent Insider Transactions • Sep 10Key Executive recently sold €115k worth of stockOn the 5th of September, Ian Delaney sold around 47k shares on-market at roughly €2.44 per share. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. Despite the recent sale, Ian has been a net buyer over the last 12 months, purchasing a net total of €436k worth of shares.
Reported Earnings • Aug 16Second quarter 2023 earnings releasedSecond quarter 2023 results: Revenue: US$35.9m (up US$35.5m from 2Q 2022). Net income: US$31.4m (up US$32.9m from 2Q 2022). Profit margin: 87% (up from net loss in 2Q 2022). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 125% per year but the company’s share price has only increased by 22% per year, which means it is significantly lagging earnings growth.
Board Change • Jun 01Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 4 highly experienced directors. Independent Director Kevin Parker was the last director to join the board, commencing their role in 2020. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Recent Insider Transactions • May 25Chief Financial Officer recently bought €54k worth of stockOn the 19th of May, Glenn MacNeil bought around 25k shares on-market at roughly €2.16 per share. This transaction amounted to 7.1% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Glenn has been a buyer over the last 12 months, purchasing a net total of €93k worth in shares.
Reported Earnings • May 18First quarter 2023 earnings released: EPS: US$0.67 (vs US$0.025 in 1Q 2022)First quarter 2023 results: EPS: US$0.67 (up from US$0.025 in 1Q 2022). Revenue: US$98.8m (up US$91.8m from 1Q 2022). Net income: US$94.5m (up US$91.0m from 1Q 2022). Profit margin: 96% (up from 50% in 1Q 2022). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 115% per year but the company’s share price has only increased by 25% per year, which means it is significantly lagging earnings growth.
Reported Earnings • Mar 31Full year 2022 earnings released: EPS: US$0.13 (vs US$0.20 in FY 2021)Full year 2022 results: EPS: US$0.13 (down from US$0.20 in FY 2021). Revenue: US$27.4m (down 19% from FY 2021). Net income: US$18.0m (down 36% from FY 2021). Profit margin: 66% (down from 84% in FY 2021). The decrease in margin was primarily driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 72% per year but the company’s share price has only increased by 24% per year, which means it is significantly lagging earnings growth.
Recent Insider Transactions • Jan 27Insider recently bought €247k worth of stockOn the 24th of January, Parag Shah bought around 125k shares on-market at roughly €1.98 per share. This transaction amounted to 5.0% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought €845k more in shares than they have sold in the last 12 months.
Reported Earnings • Nov 16Third quarter 2022 earnings released: US$0.12 loss per share (vs US$0.011 profit in 3Q 2021)Third quarter 2022 results: US$0.12 loss per share (down from US$0.011 profit in 3Q 2021). Net loss: US$16.8m (down US$18.4m from profit in 3Q 2021). Revenue is forecast to grow 240% p.a. on average during the next 2 years, compared to a 4.4% growth forecast for the Capital Markets industry in Germany. Over the last 3 years on average, earnings per share has increased by 31% per year but the company’s share price has fallen by 1% per year, which means it is significantly lagging earnings.
Reported Earnings • Nov 12Third quarter 2022 earnings released: US$0.12 loss per share (vs US$0.011 profit in 3Q 2021)Third quarter 2022 results: US$0.12 loss per share (down from US$0.011 profit in 3Q 2021). Net loss: US$16.8m (down US$18.4m from profit in 3Q 2021). Revenue is forecast to grow 152% p.a. on average during the next 2 years, compared to a 4.4% growth forecast for the Capital Markets industry in Germany. Over the last 3 years on average, earnings per share has increased by 31% per year but the company’s share price has fallen by 1% per year, which means it is significantly lagging earnings.
Reported Earnings • Aug 13Second quarter 2022 earnings released: US$0.011 loss per share (vs US$0.076 profit in 2Q 2021)Second quarter 2022 results: US$0.011 loss per share (down from US$0.076 profit in 2Q 2021). Revenue: US$388.0k (down 96% from 2Q 2021). Net loss: US$1.58m (down 115% from profit in 2Q 2021). Over the next year, revenue is forecast to grow 169% compared to a 2.6% decline forecast for the industry in Germany. Over the last 3 years on average, earnings per share has increased by 14% per year but the company’s share price has only increased by 4% per year, which means it is significantly lagging earnings growth.
Recent Insider Transactions • Jun 17Insider recently bought €369k worth of stockOn the 14th of June, Parag Shah bought around 200k shares on-market at roughly €1.84 per share. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought €5.7m more in shares than they have sold in the last 12 months.
Recent Insider Transactions • Jun 01Lead Independent Director recently bought €191k worth of stockOn the 30th of May, Stephen Cole bought around 100k shares on-market at roughly €1.91 per share. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought €5.4m more in shares than they have sold in the last 12 months.
Reported Earnings • May 18First quarter 2022 earnings released: EPS: US$0.025 (vs US$0.064 in 1Q 2021)First quarter 2022 results: EPS: US$0.025 (down from US$0.064 in 1Q 2021). Revenue: US$7.01m (down 45% from 1Q 2021). Net income: US$3.52m (down 61% from 1Q 2021). Profit margin: 50% (down from 72% in 1Q 2021). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 6% per year but the company’s share price has remained flat, which means it is well ahead of earnings.
Reported Earnings • Apr 15Full year 2021 earnings releasedFull year 2021 results: Revenue: US$33.7m (down 230% from FY 2020). Net income: US$28.2m (up US$62.6m from FY 2020). Profit margin: 84% (down from 132% in FY 2020). The decrease in margin was driven by lower revenue. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 63 percentage points per year, which is a significant difference in performance.
Recent Insider Transactions • Jan 28Insider recently bought €84k worth of stockOn the 24th of January, Parag Shah bought around 50k shares on-market at roughly €1.69 per share. In the last 3 months, there was an even bigger purchase from another insider worth €1.2m. Insiders have collectively bought €6.2m more in shares than they have sold in the last 12 months.
Recent Insider Transactions • Dec 08Insider recently bought €440k worth of stockOn the 3rd of December, James Hays bought around 250k shares on-market at roughly €1.76 per share. In the last 3 months, they made an even bigger purchase worth €1.2m. Insiders have collectively bought €6.1m more in shares than they have sold in the last 12 months.
Recent Insider Transactions • Nov 25Insider recently bought €108k worth of stockOn the 22nd of November, James Hays bought around 60k shares on-market at roughly €1.81 per share. In the last 3 months, they made an even bigger purchase worth €2.0m. Insiders have collectively bought €4.6m more in shares than they have sold in the last 12 months.
Reported Earnings • Nov 19Third quarter 2021 earnings releasedThe company reported a decent third quarter result with improved earnings and profit margins, although revenues were weaker. Third quarter 2021 results: Revenue: US$3.80m (down 6.1% from 3Q 2020). Net income: US$1.59m (up 143% from 3Q 2020). Profit margin: 42% (up from 16% in 3Q 2020). The increase in margin was driven by lower expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 85 percentage points per year, which is a significant difference in performance.
Recent Insider Transactions • Sep 12Chief Financial Officer recently bought €58k worth of stockOn the 9th of September, Glenn MacNeil bought around 32k shares on-market at roughly €1.81 per share. In the last 3 months, there was an even bigger purchase from another insider worth €2.0m. Glenn has been a buyer over the last 12 months, purchasing a net total of €115k worth in shares.
Recent Insider Transactions • Aug 29Insider recently bought €2.0m worth of stockOn the 26th of August, James Hays bought around 1m shares on-market at roughly €1.63 per share. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought €8.0m more in shares than they have sold in the last 12 months.
Reported Earnings • Aug 20Second quarter 2021 earnings releasedSecond quarter 2021 results: Revenue: US$10.5m (up 182% from 2Q 2020). Net income: US$10.9m (up US$11.0m from 2Q 2020). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 88 percentage points per year, which is a significant difference in performance.
Recent Insider Transactions • Jul 28Insider recently bought €994k worth of stockOn the 19th of July, James Hays bought around 750k shares on-market at roughly €1.33 per share. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought €6.0m more in shares than they have sold in the last 12 months.
Reported Earnings • May 24First quarter 2021 earnings releasedThe company reported a soft first quarter result with weaker revenues and profit margins, although earnings were improved. First quarter 2021 results: Revenue: US$12.7m (down 153% from 1Q 2020). Net income: US$9.09m (up US$29.5m from 1Q 2020). Profit margin: 72% (down from 86% in 1Q 2020). The decrease in margin was driven by lower expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 89 percentage points per year, which is a significant difference in performance.
Recent Insider Transactions • Apr 24Insider recently bought €258k worth of stockOn the 16th of April, James Hays bought around 137k shares on-market at roughly €1.88 per share. In the last 3 months, there was an even bigger purchase from another insider worth €509k. Insiders have collectively bought €11m more in shares than they have sold in the last 12 months.
Recent Insider Transactions • Apr 01Executive Chairman of the Board recently bought €295k worth of stockOn the 29th of March, Ian Delaney bought around 165k shares on-market at roughly €1.79 per share. This was the largest purchase by an insider in the last 3 months. This was Ian's only on-market trade for the last 12 months.
Reported Earnings • Mar 27Full year 2020 earnings releasedFull year 2020 results: Net loss: US$34.4m (down US$42.9m from profit in FY 2019).
Is New 90 Day High Low • Mar 05New 90-day high: €1.80The company is up 22% from its price of €1.48 on 04 December 2020. The German market is up 8.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Capital Markets industry, which is up 10.0% over the same period.
Is New 90 Day High Low • Feb 03New 90-day high: €1.68The company is up 12% from its price of €1.50 on 05 November 2020. The German market is up 16% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Capital Markets industry, which is up 14% over the same period.
Is New 90 Day High Low • Jan 14New 90-day high: €1.62The company is up 7.0% from its price of €1.52 on 16 October 2020. The German market is up 10.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Capital Markets industry, which is up 12% over the same period.
Is New 90 Day High Low • Dec 17New 90-day high: €1.54The company is up 10.0% from its price of €1.40 on 18 September 2020. The German market is up 2.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Capital Markets industry, which is up 4.0% over the same period.
Recent Insider Transactions • Dec 03Insider recently bought €374k worth of stockOn the 30th of November, James Hays bought around 250k shares on-market at roughly €1.50 per share. In the last 3 months, they made an even bigger purchase worth €1.4m. Insiders have collectively bought €11m more in shares than they have sold in the last 12 months.
Reported Earnings • Nov 14Third quarter 2020 earnings released: EPS US$0.005Third quarter 2020 results: Net income: US$655.0k (down 83% from 3Q 2019).
Is New 90 Day High Low • Nov 10New 90-day high: €1.53The company is up 17% from its price of €1.31 on 12 August 2020. The German market is flat over the last 90 days, indicating the company outperformed over that time. It also outperformed the Capital Markets industry, which is down 3.0% over the same period.
Is New 90 Day High Low • Oct 05New 90-day high: €1.46The company is up 12% from its price of €1.30 on 07 July 2020. The German market is flat over the last 90 days, indicating the company outperformed over that time. It also outperformed the Capital Markets industry, which is down 12% over the same period.
Recent Insider Transactions • Sep 30Insider recently bought €203k worth of stockOn the 25th of September, James Hays bought around 143k shares on-market at roughly €1.42 per share. In the last 3 months, there was an even bigger purchase from another insider worth €616k. Insiders have collectively bought €7.7m more in shares than they have sold in the last 12 months.